Back


08/11/2017
Interim report for the first nine months of 2017
Zealand Pharma A/S (“ZEAL”) announces financial results and continued strong progress for its product candidates and business for the first nine months of 2017. Financial guidance for 2017 has been revised with 4-6% lower operating expenses. [...]

Download the pdf file





X

X